Patents by Inventor Alexander Kaever

Alexander Kaever has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220226318
    Abstract: The present invention relates to compounds for the treatment of diseases related to DUX4 expression, such as muscular dystrophies, wherein the disease is facioscapulohumeral muscular dystrophy (FSHD). It also relates to use of such compounds, or to methods of use of such compounds.
    Type: Application
    Filed: January 13, 2022
    Publication date: July 21, 2022
    Applicant: Facio Intellectual Property B.V.
    Inventors: Joris De Maeyer, Marcus Geese, Martin Schneider, Sebastian Monecke, Alexander Kaever, Monika Ermann, Timothy Robin James
  • Publication number: 20210177847
    Abstract: The present invention relates to compounds for the treatment of diseases related to DUX4 expression, such as muscular dystrophies. It also relates to use of such compounds, or to methods of use of such compounds.
    Type: Application
    Filed: December 13, 2018
    Publication date: June 17, 2021
    Applicant: Facio Intellectual Property B.V.
    Inventors: Joris De Maeyer, Marcus Geese, Martin Schneider, Sebastian Monecke, Alexander Kaever, Monika Ermann, Timothy Robin James
  • Patent number: 10973820
    Abstract: The present invention relates to compounds for the treatment of diseases related to DUX4 expression, such as muscular dystrophies, wherein the disease is facioscapulohumeral muscular dystrophy (FSHD). It also relates to use of such compounds, or to methods of use of such compounds.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: April 13, 2021
    Assignee: Facio Intellectual Property B.V.
    Inventors: Joris de Maeyer, Marcus Geese, Martin Schneider, Sebastian Monecke, Alexander Kaever, Monika Ermann, Timothy Robin James
  • Publication number: 20190175596
    Abstract: The present invention relates to compounds for the treatment of diseases related to DUX4 expression, such as muscular dystrophies, wherein the disease is facioscapulohumeral muscular dystrophy (FSHD). It also relates to use of such compounds, or to methods of use of such compounds.
    Type: Application
    Filed: December 12, 2018
    Publication date: June 13, 2019
    Applicant: Facio Intellectual Property B.V.
    Inventors: Joris de Maeyer, Marcus Geese, Martin Schneider, Sebastian Monecke, Alexander Kaever, Monika Ermann, Timothy Robin James